Drug Shortage Report for AURO-ATORVASTATIN
| Report ID | 129760 |
| Drug Identification Number | 02407264 |
| Brand name | AURO-ATORVASTATIN |
| Common or Proper name | Atorvastatin |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90, 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-12-04 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2020-10-22 |
| Shortage status | Avoided shortage |
| Updated date | 2021-01-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2021-01-07 | French | Compare |
| v9 | 2021-01-07 | French | Compare |
| v8 | 2021-01-07 | English | Compare |
| v7 | 2020-12-24 | French | Compare |
| v6 | 2020-12-24 | French | Compare |
| v5 | 2020-12-24 | English | Compare |
| v4 | 2020-12-21 | French | Compare |
| v3 | 2020-12-21 | English | Compare |
| v2 | 2020-12-07 | French | Compare |
| v1 | 2020-12-07 | English | Compare |
Showing 1 to 10 of 10